{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:06:13Z","timestamp":1784664373685,"version":"3.55.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Idiopathic multicentric Castleman disease (iMCD) is a benign lymphoproliferative disease characterised by generalised lymphadenopathy and systemic inflammatory symptoms, occurring in individuals without an infection with human immunodeficiency virus or Kaposi sarcoma-associated herpesvirus. iMCD is typically subclassified into iMCD-TAFRO, which is characterised by thrombocytopenia, ascites, fever, reticulin fibrosis, and organomegaly; iMCD with idiopathic plasmacytic lymphadenopathy, which follows a chronic disease course with persistent lymphadenopathy, marked polyclonal hypergammaglobulinemia, and prominent plasma cell infiltration in the lymph nodes; and iMCD-not otherwise specified, which lacks features of both TAFRO syndrome and the idiopathic plasmacytic lymphadenopathy phenotype. Pleural thickening and effusion are extremely rare manifestations of iMCD-not otherwise specified. Herein, we present a rare case of iMCD-not otherwise specified presenting with unilateral pleural thickening and pleural effusion. A 76-year-old Japanese man was referred for further evaluation of a massive left-sided pleural effusion with tracheal compression. Fluorodeoxyglucose positron emission tomography\/computed tomography showed increased uptake in the thickened pleura and multiple lymph nodes. Histopathological examination of a mediastinal lymph node demonstrated medullary and lymphoid follicular hyperplasia without structural destruction, while a biopsy of the thickened pleura showed infiltration of lymphocytes and plasma cells without dysplasia. The patient was treated with corticosteroids and tocilizumab, resulting in a marked improvement in his symptoms and pleural effusion. This case highlights the importance of considering pleural and lymph node biopsies for an accurate diagnosis and of not excluding iMCD in patients with unilateral pleural thickening accompanied by multiple lymphadenopathies.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag056","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:45:58Z","timestamp":1782992758000},"source":"Crossref","is-referenced-by-count":0,"title":["Idiopathic multicentric Castleman disease complicated by unilateral pleural thickening and massive pleural effusion: A case report"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1634-094X","authenticated-orcid":false,"given":"Yuki","family":"Aitani","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]},{"name":"Department of Immunology, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9856-9681","authenticated-orcid":false,"given":"Shion","family":"Kachi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-5712","authenticated-orcid":false,"given":"Ryosuke","family":"Hiwa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kyoto University Hospital , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Sumitomo","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kyoto University Hospital , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kitajima","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kyoto Okamoto Memorial Hospital , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1135-0463","authenticated-orcid":false,"given":"Mirei","family":"Shirakashi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9670-9206","authenticated-orcid":false,"given":"Shuji","family":"Akizuki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-0647","authenticated-orcid":false,"given":"Ran","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-4900","authenticated-orcid":false,"given":"Hajime","family":"Yoshifuji","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-2933","authenticated-orcid":false,"given":"Masao","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-638X","authenticated-orcid":false,"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"2026072115313733300_ref1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","article-title":"Castleman disease","volume":"7","author":"Carbone","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026072115313733300_ref2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1053\/j.semdp.2016.05.006","article-title":"Multicentric Castleman disease: where are we now?","volume":"33","author":"Wang","year":"2016","journal-title":"Semin Diagn Pathol"},{"key":"2026072115313733300_ref3","first-page":"252","article-title":"Clinicopathological analysis of systemic nodal plasmacytosis with severe polyclonal hyperimmunoglobulinemia","volume":"67","author":"Mori","year":"1978","journal-title":"Proc Jpn Soc Pathol"},{"key":"2026072115313733300_ref4","first-page":"55","article-title":"Idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia: a syndrome related to giant lymph node hyperplasia of plasma cell type","volume":"20","author":"Mori","year":"1980","journal-title":"J Jpn Soc Lymphoreticular Tissue Res"},{"key":"2026072115313733300_ref5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/1066896908315812","article-title":"Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases","volume":"16","author":"Kojima","year":"2008","journal-title":"Int JSurg Pathol"},{"key":"2026072115313733300_ref6","doi-asserted-by":"publisher","first-page":"10301","DOI":"10.3390\/ijms231810301","article-title":"Idiopathic plasmacytic lymphadenopathy forms an independent subtype of idiopathic multicentric Castleman disease","volume":"23","author":"Nishikori","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026072115313733300_ref7","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/bjh.19334","article-title":"Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: a distinct subtype of iMCD-not otherwise specified with different clinical features and better survival","volume":"204","author":"Gao","year":"2024","journal-title":"Br J Haematol"},{"key":"2026072115313733300_ref8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.chest.2023.03.022","article-title":"Evolution of pulmonary involvement in idiopathic multicentric Castleman disease-not otherwise specified: from nodules to cysts or consolidation","volume":"164","author":"Zhou","year":"2023","journal-title":"Chest"},{"key":"2026072115313733300_ref9","first-page":"2196","article-title":"Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease","volume":"109","author":"Bustamante","year":"2024","journal-title":"Haematologica."},{"key":"2026072115313733300_ref10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3960\/jslrt.24053","article-title":"Computed tomography findings of idiopathic multicentric Castleman disease subtypes","volume":"64","author":"Iguchi","year":"2024","journal-title":"J Clin Exp Hematop"},{"key":"2026072115313733300_ref11","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"23","author":"Fajgenbaum","year":"2017","journal-title":"Blood."},{"key":"2026072115313733300_ref12","doi-asserted-by":"publisher","first-page":"100720","DOI":"10.1016\/j.lanwpc.2023.100720","article-title":"A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria","volume":"34","author":"Zhang","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"2026072115313733300_ref13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1378\/chest.112.3.702","article-title":"The optimal number of pleural biopsy specimens for a diagnosis of tuberculous pleurisy","volume":"112","author":"Kirsch","year":"1997","journal-title":"Chest."},{"key":"2026072115313733300_ref14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/resp.13673","article-title":"Tuberculous pleural effusion","volume":"24","author":"Shaw","year":"2019","journal-title":"Respirology."},{"key":"2026072115313733300_ref15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1164\/rccm.2111019","article-title":"Yield of sputum induction in the diagnosis of pleural tuberculosis","volume":"167","author":"Conde","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072115313733300_ref16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1183\/09031936.03.00017103a","article-title":"Diagnostic tools in tuberculous pleurisy: a direct comparative study","volume":"22","author":"Diacon","year":"2003","journal-title":"Eur Respir J"},{"key":"2026072115313733300_ref17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1378\/chest.06-2063","article-title":"Diagnosis and treatment of tuberculous pleural effusion in 2006","volume":"131","author":"Gopi","year":"2007","journal-title":"Chest."},{"key":"2026072115313733300_ref18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12890-015-0019-x","article-title":"Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital","volume":"15","author":"Luo","year":"2015","journal-title":"BMC Pulm Med"},{"key":"2026072115313733300_ref19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/hon.2135","article-title":"Incidence and risk factors of pleural effusions in patients with POEMS syndrome","volume":"33","author":"Cui","year":"2015","journal-title":"Hematol Oncol"},{"key":"2026072115313733300_ref20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/0961203310381510","article-title":"Multicentric Castleman's disease representing effusion at initial clinical presentation: clinicopathological study of seven cases","volume":"20","author":"Kojima","year":"2011","journal-title":"Lupus."},{"key":"2026072115313733300_ref21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0046-8177(85)80065-4","article-title":"Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases","volume":"16","author":"Weisenburger","year":"1985","journal-title":"Hum Pathol"},{"key":"2026072115313733300_ref22","first-page":"e47035","article-title":"Castleman disease in an older patient with the onset of right pleural effusion","volume":"15","author":"Takao","year":"2023","journal-title":"Cureus."},{"key":"2026072115313733300_ref23","first-page":"288","article-title":"Idiopathic Plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia and pleural effusion","volume":"38","author":"Mori","year":"2000","journal-title":"Ann Jpn Res Soc"},{"key":"2026072115313733300_ref24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.102.4.1055","article-title":"Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity","volume":"102","author":"Yokoyama","year":"1992","journal-title":"Chest."},{"key":"2026072115313733300_ref25","first-page":"1705","article-title":"Distinct interleukin-6 production in IPL and TAFRO subtypes of idiopathic multicentric Castleman disease","volume":"111","author":"Nishikori","year":"2025","journal-title":"Haematologica."},{"key":"2026072115313733300_ref26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41379-021-00950-3","article-title":"Transcriptome and unique cytokine microenvironment of Castleman disease","volume":"35","author":"Wing","year":"2022","journal-title":"Mod Pathol"},{"key":"2026072115313733300_ref27","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jha2.1034","article-title":"Interleukin-6 transcripts up-regulation in lymph nodes from unicentric and multicentric Castleman disease","volume":"5","author":"Lucioni","year":"2024","journal-title":"EJHaem."},{"key":"2026072115313733300_ref28","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1182\/blood.2023021992","article-title":"Single-cell landscape of idiopathic multicentric Castleman disease in identical twins","volume":"143","author":"Chan","year":"2024","journal-title":"Blood."},{"key":"2026072115313733300_ref29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12890-021-01603-6","article-title":"IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung","volume":"21","author":"Kinugawa","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2026072115313733300_ref30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.prp.2018.12.025","article-title":"An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome","volume":"215","author":"Kurose","year":"2019","journal-title":"Pathol Res Pract"},{"key":"2026072115313733300_ref31","first-page":"343","article-title":"A case of multicentric Castleman\u2019s disease with pleural effusion and high levels of adenosine deaminase and IgG4, diagnosed by mediastinal lymph node biopsy","volume":"10","author":"Takahashi","year":"2021","journal-title":"Ann Jpn Resp Soc"},{"key":"2026072115313733300_ref32","first-page":"7","article-title":"Molecular forms of adenosine deaminase in pleural effusions","volume":"40","author":"Ungerer","year":"1988","journal-title":"Enzyme."},{"key":"2026072115313733300_ref33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.121.3.815","article-title":"Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions","volume":"121","author":"Xirouchaki","year":"2002","journal-title":"Chest."},{"key":"2026072115313733300_ref34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/000313481508100426","article-title":"The surgical anatomy of the inguinal lymphatics","volume":"81","author":"Cesmebasi","year":"2015","journal-title":"Am Surg"},{"key":"2026072115313733300_ref35","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1183\/09031936.97.10102411","article-title":"Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy","volume":"10","author":"Kroegel","year":"1997","journal-title":"Eur Respir J"},{"key":"2026072115313733300_ref36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1165\/ajrcmb.14.6.8652179","article-title":"Interleukin 6 is an autocrine growth factor for normal human pleural mesothelial cells","volume":"14","author":"Fujino","year":"1996","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag056\/68684461\/rxag056.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag056\/68684461\/rxag056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag056\/68684461\/rxag056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:31:46Z","timestamp":1784662306000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag056\/8723801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag056","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag056"}}